These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

410 related items for PubMed ID: 16682587

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study.
    Miller JW, Schmidt-Erfurth U, Sickenberg M, Pournaras CJ, Laqua H, Barbazetto I, Zografos L, Piguet B, Donati G, Lane AM, Birngruber R, van den Berg H, Strong A, Manjuris U, Gray T, Fsadni M, Bressler NM, Gragoudas ES.
    Arch Ophthalmol; 1999 Sep; 117(9):1161-73. PubMed ID: 10496388
    [Abstract] [Full Text] [Related]

  • 24. Photodynamic therapy with verteporfin following transpupillary thermotherapy for CNV evolving from an initially occult to a predominantly classic form, in patients with AMD.
    Hamon F, Goeminne P.
    Semin Ophthalmol; 2001 Dec; 16(4):223-32. PubMed ID: 15513445
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Verteporfin photodynamic therapy for extrafoveal choroidal neovascularisation secondary to age-related macular degeneration.
    Voelker M, Gelisken F, Ziemssen F, Wachtlin J, Grisanti S.
    Graefes Arch Clin Exp Ophthalmol; 2005 Dec; 243(12):1241-6. PubMed ID: 16010552
    [Abstract] [Full Text] [Related]

  • 27. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study.
    Brown DM, Michels M, Kaiser PK, Heier JS, Sy JP, Ianchulev T, ANCHOR Study Group.
    Ophthalmology; 2009 Jan; 116(1):57-65.e5. PubMed ID: 19118696
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin in the ocular histoplasmosis syndrome: one-year results of an uncontrolled, prospective case series.
    Saperstein DA, Rosenfeld PJ, Bressler NM, Rosa RH, Sickenberg M, Sternberg P, Aaberg TM, Aaberg TM, Reaves TA, Verteporfin in Ocular Histoplasmosis (VOH) Study Group.
    Ophthalmology; 2002 Aug; 109(8):1499-505. PubMed ID: 12153802
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Clinical trial of verteporfin photodynamic therapy in Chinese age-related macular degeneration with subfoveal predominant choroidal neovascularization patients].
    Chen YX, Ge J, Yan M, Jin CJ, Zhang MX, Dong FT, Lu F, Zhang CF, Zhao JL.
    Zhonghua Yan Ke Za Zhi; 2007 Mar; 43(3):198-205. PubMed ID: 17605900
    [Abstract] [Full Text] [Related]

  • 32. Spotlight on verteporfin in subfoveal choroidal neovascularisation.
    Keam SJ, Scott LJ, Curran MP.
    Drugs Aging; 2004 Mar; 21(3):203-9. PubMed ID: 14979737
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Photodynamic therapy with verteporfin in Belgian patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration.
    Mori R, Kelkar A, De Laey JJ.
    Bull Soc Belge Ophtalmol; 2006 Mar; (299):57-64. PubMed ID: 16681088
    [Abstract] [Full Text] [Related]

  • 35. [Photodynamic therapy in age-related macular degeneration--results of one year observation].
    Wykrota H, Gierek-Łapińska A.
    Klin Oczna; 2002 Mar; 104(3-4):239-43. PubMed ID: 12608309
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Verteporfin therapy in occult with no classic CNV due to AMD: results of the Photodynamic Therapy in Occult-Only Lesions study.
    Soubrane G, Harding SP, Wolf S, Weichselberger A.
    Eye (Lond); 2009 Apr; 23(4):791-800. PubMed ID: 18583995
    [Abstract] [Full Text] [Related]

  • 39. Triamcinolone acetonide as adjunctive treatment to verteporfin in neovascular age-related macular degeneration: a prospective randomized trial.
    Chaudhary V, Mao A, Hooper PL, Sheidow TG.
    Ophthalmology; 2007 Dec; 114(12):2183-9. PubMed ID: 18054638
    [Abstract] [Full Text] [Related]

  • 40. Photodynamic therapy with verteporfin in ocular histoplasmosis: uncontrolled, open-label 2-year study.
    Rosenfeld PJ, Saperstein DA, Bressler NM, Reaves TA, Sickenberg M, Rosa RH, Sternberg P, Aaberg TM, Aaberg TM, Verteporfin in Ocular Histoplasmosis Study Group.
    Ophthalmology; 2004 Sep; 111(9):1725-33. PubMed ID: 15350329
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.